Reducing Frailty for Older Cancer Survivors Using Supplements II
Status:
Not yet recruiting
Trial end date:
2030-12-31
Target enrollment:
Participant gender:
Summary
This study is a two-arm placebo controlled randomized clinical trial, to assess the effect of
a 12-week EGCG intervention on physical frailty compared to placebo in pre-frail older cancer
survivors.